In March 2025, the company introduced new plans for the immediate-to-shopper providing of its Wegovy weight loss drug. The company set up a completely new pharmacy, known as NovoCare, which would charge consumers $499 a month for use of the drug, below 50 percent the expense of the drug via other pharmaceutical distribution networks.[53]that can he